The S&P 500 has had a volatile start to 2025 but has still managed to gain 3.8% year to date as of market close on Jan. 24.

It was about a year ago that shares of Iovance Biotherapeutics ( IOVA -1.94%) began to take off. The stock soared on news of approval from the Food and Drug Administration for Amtagvi (lifileucel) as ...

Looking ahead to fiscal 2025, Tractor Supply is targeting net sales growth in the mid-single digits, with an EPS range ...

Palantir would need to grow into a $6.7 trillion market cap to turn a $25,000 investment into $1 million. This would be its ...

The transformative power of artificial intelligence (AI) is undeniable. A recent McKinsey & Company research report estimates ...

Realty Income has increased its dividend for 109 quarters in a row. Brookfield Infrastructure has raised its dividend every ...

With growth coming in hot, Axon Enterprise's shareholders enjoyed a great year. In 2024, Axon stock jumped 130%, skyrocketing ...

Buffett's largest holding at Berkshire is counting on artificial intelligence (AI) to reignite its growth engine. Meanwhile, ...

Chinese research lab DeepSeek just upended the artificial intelligence (AI) industry with its new, hyper-efficient models.

Microsoft posted strong Q2 2025 earnings, beating expectations with robust cloud and AI growth, though it faces challenges in ...

If you want to get the most out of your 401 (k) account, you obviously need to contribute money of your own. But you also ...

The latest U.S. Federal Reserve meeting saw interest rates remain on hold as it seeks to make more progress on lowering ...